MedPath

The Effect of Clove Extract on Pain Caused by Copamer Injection in Patients with MS.

Phase 3
Conditions
Pain during copamer injection in Multiple Sclerosis disease.
Multiple sclerosis
Registration Number
IRCT20171216037910N3
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Age: 18-40 years old
BMI: 19- 25
No diabetic neuropathy based on the history and diagnosis of the treating physician
Full consciousness and the ability to analyze the amount of pain
Absence of scars and lesions at the injection site
Do not receive meperidine 4 hours and morphine 5 hours before intervention
Use of Copamer(Glatiramer Acetate) injection medication in patients with MS

Exclusion Criteria

Patient's sensitivity to clove extract
Coagulation problem
Need subcutaneous injection of another medication in the area of copamer injection
Chronic pain at the site of copamer injection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score in injection site after Copamer administration. Timepoint: Immediately after injection. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath